ANTHEM2026-01-012026-03-31ANTHEM2026-03-31ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors1ANTHEM2026-03-31CompositionOfBoardOfDirectors1ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors2ANTHEM2026-03-31CompositionOfBoardOfDirectors2ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors3ANTHEM2026-03-31CompositionOfBoardOfDirectors3ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors4ANTHEM2026-03-31CompositionOfBoardOfDirectors4ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors5ANTHEM2026-03-31CompositionOfBoardOfDirectors5ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors6ANTHEM2026-03-31CompositionOfBoardOfDirectors6ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors7ANTHEM2026-03-31CompositionOfBoardOfDirectors7ANTHEM2026-01-012026-03-31CompositionOfBoardOfDirectors8ANTHEM2026-03-31CompositionOfBoardOfDirectors8ANTHEM2026-01-012026-03-31CompositionOfCommittees14ANTHEM2026-03-31CompositionOfCommittees14ANTHEM2026-01-012026-03-31CompositionOfCommittees15ANTHEM2026-03-31CompositionOfCommittees15ANTHEM2026-01-012026-03-31CompositionOfCommittees16ANTHEM2026-03-31CompositionOfCommittees16ANTHEM2026-01-012026-03-31CompositionOfCommittees17ANTHEM2026-03-31CompositionOfCommittees17ANTHEM2026-01-012026-03-31CompositionOfCommittees41ANTHEM2026-03-31CompositionOfCommittees41ANTHEM2026-01-012026-03-31CompositionOfCommittees42ANTHEM2026-03-31CompositionOfCommittees42ANTHEM2026-01-012026-03-31CompositionOfCommittees43ANTHEM2026-03-31CompositionOfCommittees43ANTHEM2026-01-012026-03-31CompositionOfCommittees44ANTHEM2026-03-31CompositionOfCommittees44ANTHEM2026-01-012026-03-31CompositionOfCommittees68ANTHEM2026-03-31CompositionOfCommittees68ANTHEM2026-01-012026-03-31CompositionOfCommittees69ANTHEM2026-03-31CompositionOfCommittees69ANTHEM2026-01-012026-03-31CompositionOfCommittees70ANTHEM2026-03-31CompositionOfCommittees70ANTHEM2026-01-012026-03-31CompositionOfCommittees71ANTHEM2026-03-31CompositionOfCommittees71ANTHEM2026-01-012026-03-31CompositionOfCommittees95ANTHEM2026-03-31CompositionOfCommittees95ANTHEM2026-01-012026-03-31CompositionOfCommittees96ANTHEM2026-03-31CompositionOfCommittees96ANTHEM2026-01-012026-03-31CompositionOfCommittees97ANTHEM2026-03-31CompositionOfCommittees97ANTHEM2026-01-012026-03-31CompositionOfCommittees98ANTHEM2026-03-31CompositionOfCommittees98ANTHEM2026-01-012026-03-31CompositionOfCommittees122ANTHEM2026-03-31CompositionOfCommittees122ANTHEM2026-01-012026-03-31CompositionOfCommittees123ANTHEM2026-03-31CompositionOfCommittees123ANTHEM2026-01-012026-03-31CompositionOfCommittees124ANTHEM2026-03-31CompositionOfCommittees124ANTHEM2026-01-012026-03-31CompositionOfCommittees125ANTHEM2026-03-31CompositionOfCommittees125ANTHEM2026-03-31MeetingOfBoardOfDirectors1ANTHEM2026-01-012026-03-31MeetingOfBoardOfDirectors1ANTHEM2026-03-31MeetingOfBoardOfDirectors2ANTHEM2026-01-012026-03-31MeetingOfBoardOfDirectors2ANTHEM2026-01-012026-03-31MeetingOfCommittees1ANTHEM2026-03-31MeetingOfCommittees1ANTHEM2026-01-012026-03-31MeetingOfCommittees2ANTHEM2026-03-31MeetingOfCommittees2ANTHEM2026-01-012026-03-31MeetingOfCommittees3ANTHEM2026-03-31MeetingOfCommittees3ANTHEM2026-01-012026-03-31MeetingOfCommittees4ANTHEM2026-03-31MeetingOfCommittees4ANTHEM2026-01-012026-03-31MeetingOfCommittees5ANTHEM2026-03-31MeetingOfCommittees5ANTHEM2026-01-012026-03-31MeetingOfCommittees6ANTHEM2026-03-31MeetingOfCommittees6ANTHEM2026-01-012026-03-31MeetingOfCommittees7ANTHEM2026-03-31MeetingOfCommittees7ANTHEM2025-12-31xbrli:pure544449ANTHEMNOTLISTEDINE0CZ201020Anthem Biosciences Limited2025-04-012026-03-31Yearly2026-03-31EquitytruetruefalseThe Company has made investments in Ampyr Renewable Energy Resources Eleven Private Limited (Ampyr) for a captive power project, in compliance with the Electricity Rules, 2005, as detailed below: 1. Approval of an investment limit of up to INR 5.30 crore pursuant to the Board resolution dated May 30, 2022; 2. Enhancement of the investment limit to INR 5.50 crore, as approved by the Board on March 14, 2023; 3. Divestment of 15,54,197 equity shares of INR 10 each, representing 5.40% shareholding, on February 15, 2026. The Company was listed on July 21, 2025 and the aforesaid investments were made prior to listing. Accordingly, the requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 were not applicable at the time of such investments. However, pursuant to Para A of Part A of Schedule III of the SEBI LODR Regulations, acquisition of shares or voting rights aggregating to 5% or more in an unlisted company and any subsequent change exceeding 2%, is required to be disclosed on a quarterly basis. While the prescribed format does not capture divestments, the same is being disclosed herein by way of this note.falseDuring the quarter ended March 31, 2026, there was no imposition of fine or penalty, in terms of sub-para 20 of Para A of Part A of Schedule III of SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015.falseThere are no updates to ongoing Tax Litigations or disputes during the quarter ended March 31, 2026 that necessitate disclosure.falseThe Company had provided Corporate Gurantee on behalf of Neoanthem Lifesciences Private Limited (Wholly Owned Subsidiary) to Citi Bank N.A. and Federal Bank Limited of Rs. 25 Crores and 24 Crores respectively to meet the workig capital requirements, pursuant to approval form the Board of Directors of the Company at its meeting held on November 08, 2025. Since the transaction is betweeen the holding company and Wholly Owned sbsidiary Company, the "Disclosure of loans/gurantees/comfort letters/securities" was selected as NOtrueAny othertruecoma01290OriginalMr. Ajay Bhardwaj is Managing Director and Chief Executive Officer of the Company and also holds the position of Chairperson of the company. Accordingly, for the disclosure related to "whether the chaiperson is related to MD or CEO" is marked as No. truefalseMrAJAY BHARDWAJ******00333704Executive DirectorChairpersonCEO-MD1960-07-20falseActiveNA2006-06-132025-06-101020MrGANESH SAMBASIVAM******01469963Executive DirectorNot Applicable1965-12-20falseActiveNA2006-08-042025-06-101000MrK RAVINDRA CHANDRAPPA******01580534Executive DirectorNot Applicable1966-11-02falseActiveNA2006-09-272025-06-101011MrRAVIKANT UPPAL******00025970Non-Executive - Independent DirectorNot Applicable1952-05-09falseActiveNA2024-09-272024-09-2718.042231MrSUBRAMANIAN MADHAVAN******06451889Non-Executive - Independent DirectorNot Applicable1956-10-27falseActiveNA2024-09-272024-09-2718.045554MrRAMESH RAMADURAI ******07109252Non-Executive - Independent DirectorNot Applicable1962-02-13falseActiveNA2024-09-272024-09-2718.042220MsSHUBHA KULKARNI******03551350Non-Executive - Independent DirectorNot Applicable1967-05-25falseActiveNA2024-09-272024-09-2718.041111MrSATISH CHANDER SUBBANNA******02849420Non-Executive - Nominee DirectorNot Applicable1975-03-11falseActiveNA2021-04-091000truetruetruetruetrueAudit Committee06451889SUBRAMANIAN MADHAVANNon-Executive - Independent DirectorChairperson2024-10-18Audit Committee00025970RAVIKANT UPPALNon-Executive - Independent DirectorMember2024-10-18Audit Committee07109252RAMESH RAMADURAINon-Executive - Independent DirectorMember2024-10-18Audit Committee00333704AJAY BHARDWAJExecutive DirectorMember2024-10-18Nomination and remuneration committee00025970RAVIKANT UPPALNon-Executive - Independent DirectorChairperson2024-10-18Nomination and remuneration committee06451889SUBRAMANIAN MADHAVANNon-Executive - Independent DirectorMember2024-10-18Nomination and remuneration committee07109252RAMESH RAMADURAINon-Executive - Independent DirectorMember2024-10-18Nomination and remuneration committee03551350SHUBHA KULKARNINon-Executive - Independent DirectorMember2024-10-18Stakeholders Relationship Committee03551350SHUBHA KULKARNINon-Executive - Independent DirectorChairperson2024-10-18Stakeholders Relationship Committee07109252RAMESH RAMADURAINon-Executive - Independent DirectorMember2024-10-18Stakeholders Relationship Committee00333704AJAY BHARDWAJExecutive DirectorMember2024-10-18Stakeholders Relationship Committee01580534K RAVINDRA CHANDRAPPAExecutive DirectorMember2024-10-18Risk Management Committee07109252RAMESH RAMADURAINon-Executive - Independent DirectorChairperson2024-10-18Risk Management Committee06451889SUBRAMANIAN MADHAVANNon-Executive - Independent DirectorMember2024-10-18Risk Management Committee00333704AJAY BHARDWAJExecutive DirectorMember2024-10-18Risk Management Committee01580534K RAVINDRA CHANDRAPPAExecutive DirectorMember2024-10-18Corporate Social Responsibility Committee00333704AJAY BHARDWAJExecutive DirectorChairperson2014-08-02Corporate Social Responsibility Committee01580534K RAVINDRA CHANDRAPPAExecutive DirectorMember2014-08-02Corporate Social Responsibility Committee01469963GANESH SAMBASIVAMExecutive DirectorMember2014-08-02Corporate Social Responsibility Committee03551350SHUBHA KULKARNINon-Executive - Independent DirectorMember2024-10-182025-11-08true8842026-02-0588true884Audit Committee2025-11-06true4430Audit Committee2025-11-081true4430Audit Committee2026-02-0588true4430Audit Committee2026-02-2014true4320Audit Committee2026-03-1320true4430Nomination and remuneration committee2026-03-13true4440Stakeholders Relationship Committee2026-03-09true4220truetruetruetrueYestruetruetrueDivya PrasadCompany Secretary and Compliance OfficerYeshttps://anthembio.com/investors/Yeshttps://anthembio.com/wp-content/uploads/2026/03/Anthem_MOA.pdfYeshttps://anthembio.com/wp-content/uploads/2025/08/Board-Composition.pdfYeshttps://anthembio.com/wp-content/uploads/2025/08/Board-of-Directors-and-Committees-of-the-Board-Appointment-Letters-Independent-Directors.pdfYeshttps://anthembio.com/wp-content/uploads/2025/08/Composition-of-Board-Committees.pdfYeshttps://anthembio.com/code-of-conduct-for-board-members-senior-management-personnel/Yeshttps://anthembio.com/whistle-blower-policy/Yeshttps://anthembio.com/nomination-and-remuneration-policy/Yeshttps://anthembio.com/policy-on-materiality-of-rpt-and-on-dealing-with-rpt/Yeshttps://anthembio.com/policy-for-determining-material-subsidiaries-as-per-the-sebi-listing-regulations/Yeshttps://anthembio.com/wp-content/uploads/2026/04/Familiarization-Programme-for-Independent-Directors.pdfYeshttps://anthembio.com/contact-us/Yeshttps://anthembio.com/contact-us/Yeshttps://anthembio.com/financial-information/Yeshttps://anthembio.com/financial-information/NAYeshttps://anthembio.com/financial-information/Yeshttps://anthembio.com/financial-information/Yeshttps://anthembio.com/investors/Yeshttps://anthembio.com/financial-information/Yeshttps://anthembio.com/wp-content/uploads/2026/03/Credit-Rating-FY-2025.pdfYeshttps://anthembio.com/investors/NAYeshttps://anthembio.com/policy-for-determination-of-material-events-and-information-under-sebi-listing-regulations/Yeshttps://anthembio.com/contact/Yeshttps://anthembio.com/investors/NAYeshttps://anthembio.com/dividend-distribution-policy/Yeshttps://anthembio.com/investors/Yeshttps://anthembio.com/anthem-employee-stock-option-plan-2024/Yeshttps://anthembio.com/investors/Yeshttps://anthembio.com/investors/YesYesYesYesYesYesYesYesYesNAYesYesYesYesYesYesYesYesYesYesYesYesYesYesYesNANANAYesYesYesYesYesNAYesYesYesNAYesYesYesYesNAYesYesYesNANADivya PrasadCompany Secretary and Compliance OfficerYesThe Company has approved the Policy on Material Subsidiary pursuant to the requirmenet of Regulation 16(1)(c) and Regulation 24 of the SEBI (Listing Obligations and Disclousre Requirements) Regukations, 2015. The Company during the financial year 2025-2026 did not have a material subsidiary and hence the requirement to comply with the governance requirements is not applicable to the Company Divya PrasadCompany Secretary and Compliance OfficerfalseDivya PrasadCompany Secretary and Compliance OfficerBangalore2026-04-2700000